ORLANDO – Add the generic industry to the list of trade groups launching a marketing campaign in the hopes of convincing lawmakers and the public that its preferred solutions are the best ones to address concerns about high drug prices.
GPhA Rebrands As AAM, Hopes To Change Tenor Of Drug Pricing Debate
How is the generic industry like Captain "Sully" trying to land a damaged plane in the Hudson River?
More from Archive
• By
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
• By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
• By
A new pilot aims to take Brazil closer to ‘digital transformation.’